Most importantly, superactive leptin receptor antagonist restored leptin-induced NO signaling in obese rats although it did not reduce but rather tended to further increase body weight, which suggests that NO deficiency results from hyperleptinemia rather than from changes of other adipokines or metabolic abnormalities associated with obesity. The gene discussed is LEP; the disease is Obesity.